| eRNAs are required for p53-dependent enhancer activity and gene transcription CA Melo, J Drost, PJ Wijchers, H van de Werken, E de Wit, JAFO Vrielink, ... Molecular cell 49 (3), 524-535, 2013 | 567 | 2013 |
| Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA N Léveillé, CA Melo, K Rooijers, A Díaz-Lagares, SA Melo, G Korkmaz, ... Nature communications 6 (1), 6520, 2015 | 179 | 2015 |
| Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression SR Baglio, T Lagerweij, M Pérez-Lanzón, XD Ho, N Léveillé, SA Melo, ... Clinical Cancer Research 23 (14), 3721-3733, 2017 | 165 | 2017 |
| Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer KJ Lenos, DM Miedema, SC Lodestijn, LE Nijman, T van den Bosch, ... Nature cell biology 20 (10), 1193-1202, 2018 | 158 | 2018 |
| Sensing of latent EBV infection through exosomal transfer of 5′ pppRNA SR Baglio, MAJ van Eijndhoven, D Koppers-Lalic, J Berenguer, ... Proceedings of the National Academy of Sciences 113 (5), E587-E596, 2016 | 157 | 2016 |
| Apc-mutant cells act as supercompetitors in intestinal tumour initiation SM van Neerven, NE de Groot, LE Nijman, BP Scicluna, MS van Driel, ... Nature 594 (7863), 436-441, 2021 | 123 | 2021 |
| Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity N Léveillé, R Elkon, V Davalos, V Manoharan, D Hollingworth, JO Vrielink, ... Nature communications 2 (1), 513, 2011 | 104 | 2011 |
| Emerging role and therapeutic potential of lncRNAs in colorectal cancer L Schwarzmueller, O Bril, L Vermeulen, N Léveillé Cancers 12 (12), 3843, 2020 | 39 | 2020 |
| Enhancer-associated RNAs as therapeutic targets N Léveillé, CA Melo, R Agami Expert Opinion on Biological Therapy 15 (5), 723-734, 2015 | 37 | 2015 |
| A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response CA Melo, N Léveillé, K Rooijers, PJ Wijchers, G Geeven, A Tal, SA Melo, ... Oncogene 35 (33), 4399-4406, 2016 | 28 | 2016 |
| Exosome-transferred lncRNAs at the core of cancer bone lesions N Léveillé, SR Baglio Critical Reviews in Oncology/Hematology 139, 125-127, 2019 | 19 | 2019 |
| Androgens down-regulate myosin light chain kinase in human prostate cancer cells N Léveillé, A Fournier, C Labrie The Journal of Steroid Biochemistry and Molecular Biology 114 (3-5), 174-179, 2009 | 18 | 2009 |
| Intestinal region-specific Wnt signalling profiles reveal interrelation between cell identity and oncogenic pathway activity in cancer development RS Adam, SM van Neerven, C Pleguezuelos-Manzano, S Simmini, ... Cancer Cell International 20, 1-15, 2020 | 10 | 2020 |
| eRNAs reach the heart of transcription CA Melo, N Léveillé, R Agami Cell research 23 (10), 1151-1152, 2013 | 9 | 2013 |
| Polycomb complex PRC1 as gatekeeper of intestinal stem cell identity N Léveillé, L Vermeulen Stem cell investigation 3, 2016 | 6 | 2016 |
| Intestinal Apc‐inactivation induces HSP25 dependency SM van Neerven, WL Smit, MS van Driel, V Kakkar, NE de Groot, ... EMBO molecular medicine 14 (12), e16194, 2022 | 1 | 2022 |
| Identifying essential long non-coding RNAs in cancer using CRISPRi-based dropout screens O Bril, LJ Schwarzmueller, LF Moreno, L Vermeulen, N Léveillé STAR protocols 4 (4), 102588, 2023 | | 2023 |
| Noncoding RNA Regulation of Health and Disease N Léveillé, CA Melo, SA Melo Epigenomics in Health and Disease, 109-126, 2016 | | 2016 |
| Caractérisation et implication de la protéine nucléolaire GLTSCR2 dans la réponse cellulaire au stress N Léveillé | | 2008 |
